[Tuberculosis and cystic fibrosis].
Mycobacterial infections are rarely reported in Cystic Fibrosis patients although they quite often develop predisposing risk factors such as underweight, secondary diabetes mellitus and chronic inflammatory pulmonary disease. Furthermore glucocorticoid therapy is mandatory in some patients. CF heterozygotes are said to have a selective advantage due to an increased host resistance against Mycobacterium tuberculosis. In this survey 1926 CF patients were investigated for the incidence of tuberculin conversion and manifest infection with mycobacterium tuberculosis in the Federal Republic of Germany (FRG). The results do not support the hypothesis of increased host resistance nor do they show any evidence of a higher risk for tuberculosis in CF. Implications for prophylactic, diagnostic and therapeutic measures are discussed in accordance to the recent epidemiologic data of tuberculosis in the FRG.
Friedrichs
F
F
Kinderklinik der RWTH Aachen.
Kusenbach
G
G
Skopnik
H
H
D000293:Adolescent; D000328:Adult; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications* / Q000235:genetics / Q000276:immunology; D006579:Heterozygote; D006801:Humans; D007113:Immunity, Innate; D012307:Risk Factors; D014376:Tuberculosis / Q000150:complications* / Q000276:immunology
Tuberkulose und Cystische Fibrose.